Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - Steven J . Buskirk, M.D.

Back to Research Profile

  1. Peterson JL, Buskirk SJ, Heckman MG, Crook JE, Ko SJ, Wehle MJ, Igel TC, Prussak KA, Pisansky TM. Late toxicity after postprostatectomy salvage radiation therapy. Radiother Oncol 2009 Nov; 93(2):203-6. Epub 2009 Sep 18.
    View PubMed
  2. Jain AK, Vallow LA, Gale AA, Buskirk SJ. Does three-dimensional external beam partial breast irradiation spare lung tissue compared with standard whole breast irradiation? Int J Radiat Oncol Biol Phys 2009 Sep 1; 75(1):82-8. Epub 2009 Feb 21.
    View PubMed
  3. Moore LF, Kransdorf MJ, Buskirk SJ, O'Connor MI, Menke DM. Radiation-induced pseudotumor following therapy for soft tissue sarcoma. Skeletal Radiol 2009 Jun; 38(6):579-84.
    View PubMed
  4. Moore LF, Kransdorf MJ, Buskirk SJ, O'Connor MI, Menke DM. Radiation-induced pseudotumor following therapy for soft tissue sarcoma. Skeletal Radiol 2009 Jun; 38(6):579-84. Epub 2009 Feb 17.
    View PubMed
  5. Parker AS, Heckman MG, Wu KJ, Crook JE, Hilton TW, Pisansky TM, Bernard JR, Schild SE, Khor LY, Hammond EH, Pollack A, Buskirk SJ. Evaluation of Ki-67 Staining Levels as an Independent Biomarker of Biochemical Recurrence After Salvage Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys 2009 May 21. [Epub ahead of print]
    View PubMed
  6. Gale AA, Jain AK, Vallow LA, Serago CF, Buskirk SJ, Heckman MG. Cardiac dose evaluation for 3-dimensional conformal partial breast irradiation compared with whole breast irradiation. J Appl Clin Med Phys 2009; 10(1):2868. Epub 2009 Jan 14.
    View PubMed
  7. Wong WW, Buskirk SJ, Schild SE, Prussak KA, Davis BJ. Combined prostate brachytherapy and short-term androgen deprivation therapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation. J Urol 2006 Nov; 176(5):2020-4.
    View PubMed
  8. Buskirk SJ, Pisansky TM, Schild SE, Macdonald OK, Wehle MJ, Kozelsky TF, Collie AC, Ferrigni RG, Myers RP, Prussak KA, Heckman MG, Crook JE, Parker AS, Igel TC. Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system. J Urol 2006 Sep; 176(3):985-90.
    View PubMed
  9. Buskirk SJ, Pisansky TM, Schild SE, Macdonald OK, Wehle MJ, Kozelsky TF, Collie AC, Ferrigni RG, Myers RP, Prussak KA, Heckman MG, Crook JE, Parkert AS, Igel TC. Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: Evaluation of prognostic factors and creation of a prognostic scoring system. J Urol 2006 Sep; 176(3):985-90.
    View PubMed
  10. Serago CF, Buskirk SJ, Igel TC, Gale AA, Serago NE, Earle JD. Comparison of daily megavoltage electronic portal imaging or kilovoltage imaging with marker seeds to ultrasound imaging or skin marks for prostate localization and treatment positioning in patients with prostate cancer. Int J Radiat Oncol Biol Phys 2006 Aug 1; 65(5):1585-92.
    View PubMed
  11. Buskirk SJ, Kraft KJ, Witt NJ, Scheuer AK, Gianforti BL, DeGuzman ML, Hunter CA, Guida M, Serago CF, Schild SE, Collie AC. Salvage radiotherapy for patients with increasing prostate-specific antigen levels after radical prostatectomy: Evaluation of the role of retrograde urethrography. Journal of Radiotherapy in Practice 2006; 5(2):117-20.
    View PubMed
  12. Buskirk S, Kraft K, Witt N, Scheuer A, Gianforti B, DeGuzman M, Hunter C, Guida M, Serago C, Schild S, Collie AC, Earle JD. Salvage Radiation Therapy for Patients with Rising Prostate Specific Antigen Levels After Radical Prostatectomy: Evaluation of the Role of Retrograde Urethrography. Journal of Radiotherapy in Practice 2006; 5:117-120.
  13. Buskirk SJ, Pinkstaff DM, Petrou SP, Wehle MJ, Broderick GA, Young PR, Weigand SD, O'Brien PC, Igel TC. Acute urinary retention after transperineal template-guided prostate biopsy. Int J Radiat Oncol Biol Phys 2004 Aug 1; 59(5):1360-6.
    View PubMed
  14. Maples WJ, Buskirk SJ. Multimodality treatment of upper extremity bone and soft tissue sarcomas. Hand Clin 2004 May; 20(2):221-5.
    View PubMed
  15. Wehle MJ, Lisson SW, Buskirk SJ, Broderick GA, Young PR, Igel TC. Prediction of genitourinary tract morbidity after brachytherapy for prostate adenocarcinoma. Mayo Clin Proc 2004 Mar; 79(3):314-7.
    View PubMed
  16. Reed D, Wallner K, Merrick G, Buskirk S, True L. Clinical correlates to PSA spikes and positive repeat biopsies after prostate brachytherapy. Urology 2003 Oct; 62(4):683-8.
    View PubMed
  17. Serago CF, Chungbin SJ, Buskirk SJ, Ezzell GA, Collie AC, Vora SA. Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy. Int J Radiat Oncol Biol Phys 2002 Aug 1; 53(5):1130-8.
    View PubMed
  18. Buskirk SJ, Pisansky TM, Atkinson EJ, Schild SE, O'Brien PC, Wolfe JT, Zincke H. Lymph node-positive prostate cancer: evaluation of the results of the combination of androgen deprivation therapy and radiation therapy. Mayo Clin Proc 2001 Jul; 76(7):702-6.
    View PubMed
  19. Woodward TA, Menke DM, Buskirk SJ. Solitary pelvic nodule: diagnosis of metastatic prostate cancer by endoscopic ultrasound-guided, fine-needle aspiration. Am J Gastroenterol 2000 Sep; 95(9):2372-3.
    View PubMed
  20. Pisansky TM, Kozelsky TF, Myers RP, Hillman DW, Blute ML, Buskirk SJ, Cheville JC, Ferrigni RG, Schild SE. Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. J Urol 2000 Mar; 163(3):845-50.
    View PubMed
  21. Serago CF, Buskirk SJ, Karstaedt N, Wehle M, Igel TC, Casale HE. A comparison of prostate iodine-125 seed dose planning using computed tomography and ultrasound imaging. Journal of Brachytherapy International 2000; 16(2):111-116.
  22. Foote RL, Buskirk SJ, Grado GL, Bonner JA. Has radiotherapy become too expensive to be considered a treatment option for early glottic cancer? Head & Neck 1997 Dec; 19(8):692-700.
    View PubMed
  23. Foo ML, Gunderson LL, Bender CE, Buskirk SJ. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 1997 Nov 1; 39(4):929-35.
    View PubMed
  24. McGinnis WL, Loprinzi CL, Buskirk SJ, Sloan JA, Drummond RG, Frank AR, Shanahan TG, Kahanic SP, Moore RL, Schild SE, Humphrey SL. Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis. J Clin Oncol 1997 Mar; 15(3):1239-43.
    View PubMed
  25. Schild SE, Buskirk SJ, Wong WW, Halyard MY, Swanson SK, Novicki DE, Ferrigni RG. The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. J Urol 1996 Nov; 156(5):1725-9.
    View PubMed
  26. Buskirk SJ, Schild SE, Durr ED, Robinow JS, Bock FF, Wolfe JT, Tomera KM, Ferrigni RG. Evaluation of serum prostate-specific antigen levels after postoperative radiation therapy for pathologic stage T3, no prostate cancer. Mayo Clin Proc 1996 Mar; 71(3):242-248.
    View PubMed
  27. Foote RL, Grado GL, Buskirk SJ, Olsen KD, Bonner JA, Earle JD, Kasperbauer JL, McCaffrey TV, Suman VJ. Radiation therapy for glottic cancer using 6-MV photons. Cancer 1996 Jan 15; 77(2):381-6.
    View PubMed
  28. Olsen KD, Caruso M, Foote RL, Stanley RJ, Lewis JE, Buskirk SJ, Frassica DA, DeSanto LW, O'Fallon WM, Hoverman VR. Primary head and neck cancer. Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement. Archives of Otolaryngology -- Head & Neck Surgery 1994 Dec; 120(12):1370-4.
    View PubMed
  29. Foote RL, Olsen KD, Buskirk SJ, Stanley RJ, Suman VJ. Laryngectomy alone for T3 glottic cancer. Head & Neck 1994 Sep-Oct; 16(5):406-12.
    View PubMed
  30. Schild SE, Wong WW, Grado GL, Buskirk SJ, Robinow JS, Frick LM, Ferrigni RG. Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy. Mayo Clin Proc 1994 Jul; 69(7):613-9.
    View PubMed
  31. Foote RL, Hilgenfeld RU, Kunselman SJ, Schaid DJ, Buskirk SJ, Grado GL, Earle JD. Radiation therapy for squamous cell carcinoma of the tonsil. Mayo Clin Proc 1994 Jun; 69(6):525-31.
    View PubMed
  32. Foote RL, Schild SE, Thompson WM, Buskirk SJ, Olsen KD, Stanley RJ, Kunselman SJ, Schaid DJ, Grill JP. Tonsil cancer. Patterns of failure after surgery alone and surgery combined with postoperative radiation therapy. Cancer 1994 May 15; 73(10):2638-47.
    View PubMed
  33. Schild SE, Scheithauer BW, Schomberg PJ, Hook CC, Kelly PJ, Frick L, Robinow JS, Buskirk SJ. Pineal parenchymal tumors. Cancer 1993 Aug 1; 72:870-880.
    View PubMed
  34. Foote RL, Olsen KD, Davis DL, Buskirk SJ, Stanley RJ, Kunselman SJ, Schaid DJ, DeSanto LW. Base of tongue carcinoma: patterns of failure and predictors of recurrence after surgery alone. Head & Neck 1993 Jul-Aug; 15(4):300-7.
    View PubMed
  35. Thompson WM, Foote RL, Olsen KD, Schaid DJ, Grado GL, Buskirk SJ, Earle JD. Postoperative irradiation for tonsillar carcinoma. Mayo Clin Proc 1993 Jul; 68(7):665-9.
    View PubMed
  36. Perniciaro CV, Buskirk SJ. Extramammary Paget's disease treated with radiotherapy. Journal of Dermatological Treatment 1993; 3:164-165.
  37. Shaw EG, Brindle JS, Creagan ET, Foote RL, Trastek VF, Buskirk SJ. Locally recurrent non-small-cell lung cancer after complete surgical resection. Mayo Clin Proc 1992 Dec; 67(12):1129-33.
    View PubMed
  38. Foote RL, Olsen KD, Kunselman SJ, Schaid DJ, Buskirk SJ, Grado GL, Earle JD. Early-stage squamous cell carcinoma of the glottic larynx managed with radiation therapy. Mayo Clin Proc 1992 Jul; 67(7):629-36.
    View PubMed
  39. Schild SE, Foote RL, Buskirk SJ, Robinow JS, Bock FF, Cupps RE, Earle JD. Results of radiotherapy for chemodectomas. Mayo Clin Proc 1992 Jun; 67(6):537-40.
    View PubMed
  40. Buskirk SJ, Gunderson LL, Schild SE, Bender CE, Williams HJ Jr, McIlrath DC, Robinow JS, Tremaine WJ, Martin JK Jr. Analysis of failure after curative irradiation of extrahepatic bile duct carcinoma. Ann Surg 1992 Feb; 215(2):125-31.
    View PubMed
  41. Schild SE, Robinow JS, Casale HE, Bellefontaine LP, Buskirk SJ. Radiotherapy treatment planning for prostate cancer in patients with prosthetic hips. Med Dosim 1992; 17(2):83-6.
  42. Schild SE, Buskirk SJ, Robinow JS, Tomera KM, Ferrigni RG, Frick LM. The results of radiotherapy for isolated elevation of serum PSA levels following radical prostatectomy. Int J Radiat Oncol Biol Phys 1992; 23(1):141-5.
    View PubMed
  43. Schild SE, Buskirk SJ, Robinow JS. Prostate cancer: retrograde urethrography to improve treatment planning for radiotherapy. Radiology 1992; 181:885-887.
  44. Schild SE, Buskirk SJ, Frick LM, Cupps RE. The results of radiotherapy for large symptomatic hemangiomas. Int J Radiat Oncol Biol Phys 1991 Aug; 21:729-735.
    View PubMed
  45. Foote RL, Buskirk SJ, Stanley RJ, Grambsch PM, Olsen KD, DeSanto LW, Earle JD, Weiland LH. Patterns of failure after total laryngectomy for glottic carcinoma. Cancer 1989 Jul 1; 64(1):143-9.
    View PubMed
  46. Foote RL, Garretson BR, Schomberg PJ, Buskirk SJ, Robertson DM, Earle JD. External beam irradiation for retinoblastoma: patterns of failure and dose-response analysis. Int J Radiat Oncol Biol Phys 1989 Mar; 16(3):823-30.
    View PubMed
  47. Martenson JA Jr, Buskirk SJ, Ilstrup DM, Banks PM, Evans RG, Colgan JP, Earle JD. Patterns of failure in primary testicular non-Hodgkin's lymphoma. J Clin Oncol 1988 Feb; 6(2):297-302.
    View PubMed
  48. Buskirk SJ, Schray MF, Podratz KC, Lee RA, Stanhope CR, Gaffey TA, Weber FC, Earle JD, Naessens JM, Malkasian GD. Ovarian dysgerminoma: a retrospective analysis of results of treatment, sites of treatment failure, and radiosensitivity. Mayo Clin Proc 1987 Dec; 62(12):1149-57.
    View PubMed
  49. Martenson JA Jr, Gunderson LL, Buskirk SJ, Nagorney DM, Martin JK, May GR, Bender CE, Tremaine WJ. Hepatic duct stricture after radical radiation therapy for biliary cancer: recurrence or fibrosis? Mayo Clin Proc 1986 Jul; 61(7):530-6.
    View PubMed
  50. Blair TJ, Evans RG, Buskirk SJ, Banks PM, Earle JD. Radiotherapeutic management of primary thyroid lymphoma. Int J Radiat Oncol Biol Phys 1985 Feb; 11(2):365-70.
    View PubMed
  51. Buskirk SJ, Gunderson LL, Adson MA, Martinez A, May GR, McIlrath DC, Nagorney DM, Edmundson GK, Bender CE, Martin JK Jr. Analysis of failure following curative irradiation of gallbladder and extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 1984 Nov; 10(11):2013-23.
    View PubMed
  52. Buskirk SJ, Evans RG, Banks PM, O'Connell MJ, Earle JD. Primary lymphoma of the testis. Int J Radiat Oncol Biol Phys 1982 Oct; 8(10):1699-703.
    View PubMed
  53. Buskirk SJ, Evans RG, Farrow GM, Earle JD. Primary retroperitoneal seminoma. Cancer 1982 May 1; 49(9):1934-6.
    View PubMed


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.